Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A generous gift of £3.5 million from Lakshmi Mittal and his family has secured the future of a critical professorship in vaccinology at the University. The post, which is currently held by Professor Adrian Hill, will be known as the Lakshmi Mittal and Family Professorship of Vaccinology in recognition of this support.

Photo of Professor Adrian Hill © Photo by John Cairns
Professor Adrian Hill at the Jenner Institute

Professor Hill is the Director of the Oxford Jenner Institute, now the largest academic vaccine centre in the world. In 2014 Professor Hill led the first clinical trial of a vaccine aimed at controlling the Ebola outbreak in West Africa, thus kickstarting an initiative at the Jenner Institute to develop vaccines for outbreak pathogens. Recently this programme has facilitated a major effort to rapidly develop a COVID-19 vaccine, with Professor Hill acting as principal investigator for the Oxford trial. The vaccine is currently undergoing human trials in the United Kingdom, Brazil and South Africa.

As well as leading the institute, Professor Hill’s own vaccine research programme has developed one of the most promising potential vaccines for malaria, which is currently in large-scale trials in sub-Saharan Africa.

Boosted by a further £1.75 million in matched funding from the University, the Mittal family’s gift has enabled the permanent endowment of the post. Not only will this allow Professor Hill to continue with his vital research, but will also help to ensure that Oxford remains at the forefront of vaccine development for generations to come.

The full story is available on the University of Oxford Development Office website

Similar stories

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.